… , and developed a battery of viral and nonviral delivery … are a limited number of
microRNA-based applications that have … into viable microRNA-based clinical tools for cancer …

… significant hurdles in therapeutic miRNA usage are the stability and the delivery system. In
… of therapeutic miRNA delivery systems that includes virus-based delivery, non-viral delivery (…

… miRNA therapeutics will have a major part in cancer therapy in the future. Specifically,
personalized cancer medicine can be accomplished by constructing the unique miRNA mimic or …

… of nanoparticles for the delivery of miRNA-based therapeutics in the treatment of cancer and
… highlighted to underline their therapeutic potential for effective and personalized medicine. …

… The systemic miRNA delivery strategy is a significant progress to overcome the … of miRNA
delivery in vivo and elevate the impact of cancer therapy. Up to now, different systemic delivery …

… Nevertheless, RV-mediated miRNA delivery has been shown to be promising in regenerative
medicine. For example, heightened expression of miR-138 in murine embryonic fibroblasts …

… Here, we introduce four widely used viral vectors for miRNA delivery including
adenovirus vectors, adeno-associated virus vectors, retroviral vectors, and lentivirus vectors. …

… been applied to correct the dysregulated miRNA in cancer cells. The authors also …
miRNA-based therapeutic agents. Expert opinion: Application of miRNA-based therapeutics for …

… inhibitors and highlights current progress in miRNA-… in miRNA delivery, we believe that
additional therapeutic approaches to modulate miRNA function will soon enter routine medical …

… MiR-34a encapsulated in a liposomal formulation, coined MRX34, was tested as a viable TS
miRNA delivery therapy in a preclinical liver cancer study. After IV injection of MRX34 in two …